Demetri Pananos
Demetri Pananos
Ph.D Candidate in Biostatistics, Western University
Verified email at uwo.ca
Title
Cited by
Cited by
Year
Critical dynamics in population vaccinating behavior
AD Pananos, TM Bury, C Wang, J Schonfeld, SP Mohanty, B Nyhan, ...
Proceedings of the National Academy of Sciences 114 (52), 13762-13767, 2017
342017
The kinetics of regeneration of rhodopsin under enzyme-limited availability of 11-cis retinoid
TD Lamb, RM Corless, AD Pananos
Vision Research 110, 23-33, 2015
72015
HLADQA1*05 genotype predicts anti‐drug antibody formation and loss of response during infliximab therapy for inflammatory bowel disease
A Wilson, C Peel, Q Wang, AD Pananos, RB Kim
Alimentary Pharmacology & Therapeutics 51 (3), 356-363, 2020
62020
A Toolbox for Rapid Quantitative Assessment of Chronological Lifespan and Survival in Saccharomyces cerevisiae
SR Chadwick, AD Pananos, SE Di Gregorio, AE Park, P Etedali‐Zadeh, ...
Traffic 17 (6), 689-703, 2016
62016
Drug interactions and pharmacogenetic factors contribute to variation in apixaban concentration in atrial fibrillation patients in routine care
M Gulilat, D Keller, B Linton, AD Pananos, D Lizotte, GK Dresser, J Alfonsi, ...
Journal of Thrombosis and Thrombolysis 49 (2), 294-303, 2020
22020
Comparisons Between Hamiltonian Monte Carlo and Maximum A Posteriori For A Bayesian Model For Apixaban Induction Dose & Dose Personalization
AD Pananos, DJ Lizotte
Machine Learning for Healthcare Conference, 397-417, 2020
2020
immunogenicity of infliximab—ready for routine prediction? Authors' reply
A Wilson, C Peel, Q Wang, AD Pananos, RB Kim
Alimentary Pharmacology & Therapeutics 51 (8), 813-814, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–7